FTC BOMBSHELL: Gender Clinics Under Federal Fire

Transgender pride flag waving at outdoor event

As the Federal Trade Commission launches a sweeping investigation into the transgender medical industry, Americans are finally getting answers to questions the establishment wished you’d never ask—and the fallout could reshape the battle over medical ethics, parental rights, and government overreach for a generation.

At a Glance

The FTC is investigating claims of deception and fraud in gender-affirming care for minors, with enforcement actions on the table.
Testimony from detransitioners and parents alleges they were misled about the risks and permanence of medical interventions.
The Trump administration has ended federal support for gender-affirming care for minors and is directing a federal crackdown on potential abuses.
State attorneys general and other agencies are preparing parallel investigations, signaling a broad legal assault on the industry.

Federal Trade Commission Turns the Spotlight on Gender-Affirming Care

The Federal Trade Commission, under Chairman Andrew Ferguson, is doing what should have been done years ago: investigating whether doctors, hospitals, and drug manufacturers have been misleading vulnerable families about the irreversible impact of puberty blockers, cross-sex hormones, and surgeries on children. The FTC’s July 9, 2025 workshop, “The Dangers of Gender-Affirming Care for Minors,” was a much-needed reality check. It assembled parents, medical watchdogs, and detransitioners—people who regret their medical transitions—who testified that they were never given the facts, only the sales pitch. Ferguson didn’t mince words, making it clear the Commission isn’t about to turn a blind eye to what he called material misstatements and omissions in the transgender care industry.

While the medical elite likes to pretend that “gender-affirming” interventions are universally safe and evidence-based, the FTC is asking the tough questions: Who benefits from fast-tracking children onto life-altering drugs? What’s being hidden from parents? And most importantly—are families being set up for heartbreak and regret by an industry chasing profit or “progress” at any cost?

Trump Administration Draws a Hard Line on Child Medicalization

President Trump has once again put the brakes on an out-of-control policy disaster, ending federal support for gender-affirming care for minors and ordering every relevant agency—DOJ, CMS, FBI—to investigate the medical, ethical, and legal chaos unleashed by Big Medicine’s gender experiment. The administration is using every tool in the federal arsenal to hold providers accountable, tying funding to recognition of biological sex and empowering the FTC to go after deceptive practices with lawsuits and civil penalties. This is what restoring sanity looks like: protecting kids and families, not indulging the latest ideological fad at taxpayer expense.

The Trump administration’s crackdown is already sending shockwaves through the industry. Hospitals and clinics that once acted with impunity are now facing real legal risk. Some are reducing or suspending services, fearing lawsuits, investigations, and public exposure. The days of rubber-stamped consent forms and one-size-fits-all “affirmation” are numbered. For years, families who dared speak out were vilified, ignored, or labeled “transphobic.” Now, their voices are being heard at the highest levels of government—and the message is unmistakable: The era of medical experimentation on minors, with zero accountability, is over.

Medical Watchdogs, Detransitioners, and Parents Finally Get a Hearing

The FTC’s investigation has opened the floodgates for medical watchdog groups like Do No Harm and for detransitioners who have long warned that the industry is rife with misinformation, coercion, and outright fraud. Testimony from people like Prisha Mosley and Claire Abernathy makes it clear: Many patients and their parents were never told the truth about permanent infertility, loss of sexual function, or the lack of long-term studies supporting these interventions. The stories are gut-wrenching, and they highlight the consequences of letting ideology trump science and common sense.

Legal experts say the FTC’s actions could set a historic precedent, bringing the full force of consumer protection law to bear on an industry that, until now, has been shielded by political correctness and professional groupthink. The fact-finding phase is underway, with the Commission collecting evidence and public input. State attorneys general, emboldened by the FTC’s lead, are preparing their own cases under unfair and deceptive practices laws. The message from government watchdogs is clear: If you lie, mislead, or conceal vital facts from families, you will face consequences.

A Crossroads for Medicine, Parental Rights, and American Values

The implications of this investigation are enormous. For medical providers, the days of no-questions-asked gender transitions for minors are ending. Strict informed consent protocols and full disclosure of risks and benefits will become the new standard. For families, especially those who lost trust in the system, the hope is that no other child will be rushed down a path they can’t reverse. For the country, this is a fight not just about medicine, but about parental rights, government transparency, and the proper limits of federal power.

As the 2026 elections loom, expect this issue to be front and center in the nation’s ongoing battle over who gets to decide what’s best for children: parents and families, or bureaucrats and activists? The Trump administration’s actions have thrown down the gauntlet—and for once, the people peddling irreversible change are the ones sweating in the spotlight. Maybe, just maybe, common sense is making a comeback.